BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16199889)

  • 21. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
    Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L
    Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
    Schwartz B; Melnikova VO; Tellez C; Mourad-Zeidan A; Blehm K; Zhao YJ; McCarty M; Adam L; Bar-Eli M
    Oncogene; 2007 Jun; 26(28):4049-58. PubMed ID: 17224907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
    Klucky B; Mueller R; Vogt I; Teurich S; Hartenstein B; Breuhahn K; Flechtenmacher C; Angel P; Hess J
    Cancer Res; 2007 Sep; 67(17):8198-206. PubMed ID: 17804733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
    Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W
    Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
    Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines.
    Grille SJ; Bellacosa A; Upson J; Klein-Szanto AJ; van Roy F; Lee-Kwon W; Donowitz M; Tsichlis PN; Larue L
    Cancer Res; 2003 May; 63(9):2172-8. PubMed ID: 12727836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression.
    Kohya N; Kitajima Y; Jiao W; Miyazaki K
    Int J Cancer; 2003 Mar; 104(1):44-53. PubMed ID: 12532418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of intercellular adhesion activates a transition from low- to high-grade human squamous cell carcinoma.
    Margulis A; Zhang W; Alt-Holland A; Pawagi S; Prabhu P; Cao J; Zucker S; Pfeiffer L; Garfield J; Fusenig NE; Garlick JA
    Int J Cancer; 2006 Feb; 118(4):821-31. PubMed ID: 16152579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cadherin loss promotes experimental metastasis of squamous cell carcinoma.
    Philippova M; Pfaff D; Kyriakakis E; Buechner SA; Iezzi G; Spagnoli GC; Schoenenberger AW; Erne P; Resink TJ
    Eur J Cancer; 2013 May; 49(8):2048-58. PubMed ID: 23369463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation.
    Bauer K; Dowejko A; Bosserhoff AK; Reichert TE; Bauer RJ
    Carcinogenesis; 2009 Oct; 30(10):1781-8. PubMed ID: 19654099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin.
    Rieber M; Strasberg Rieber M
    Int J Cancer; 2009 Oct; 125(7):1604-12. PubMed ID: 19507255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion.
    Islam S; Carey TE; Wolf GT; Wheelock MJ; Johnson KR
    J Cell Biol; 1996 Dec; 135(6 Pt 1):1643-54. PubMed ID: 8978829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo.
    Andl CD; Fargnoli BB; Okawa T; Bowser M; Takaoka M; Nakagawa H; Klein-Szanto A; Hua X; Herlyn M; Rustgi AK
    Cancer Res; 2006 Oct; 66(20):9878-85. PubMed ID: 17047049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vimentin expression in human squamous carcinoma cells: relationship with phenotypic changes and cadherin-based cell adhesion.
    Islam S; Kim JB; Trendel J; Wheelock MJ; Johnson KR
    J Cell Biochem; 2000 Apr; 78(1):141-50. PubMed ID: 10797573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of E-cadherin and scatter factor in tumor invasion and cell motility.
    Behrens J; Weidner KM; Frixen UH; Schipper JH; Sachs M; Arakaki N; Daikuhara Y; Birchmeier W
    EXS; 1991; 59():109-26. PubMed ID: 1833225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.